Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TCBX | BCAL |
|---|---|---|
| Price | $41.27 | $21.38 |
| Change today | ▼ 4.07% | ▼ 1.29% |
| Market cap | $687.35M | $687.38M |
| Return, 3 months | +3.8% | +5.0% |
| Return, year to date | +8.6% | +16.4% |
| Return, 1 year | +6.3% | +30.9% |
| P/E (TTM) | 10.3 | 11.6 |
| P/B | 1.0 | 1.2 |
| P/E percentile vs own 5y | 26th | 60th |
| Dividend yield | – | 1.40% |
| Revenue growth (YoY, latest qtr) | +30.5% | +1.4% |
| Net profit growth (YoY) | +31.3% | +1.4% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 29.6% | 33.4% |
| Return on equity | 11.9% | 10.6% |
| Analyst target vs. price | +19.5% | +14.6% |
| Analyst buy share | 33% | 100% |
| RSI (14) | 32 | 46 |
| 30-day volatility | 22.5% | 14.3% |
| Max drawdown, 1 year | -16.1% | -13.5% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
